Pharmaco in Zambia Scrutinizes the Side Effects of Medicines Launched In the Market
A new vigilant body was set up by the Zambia Pharmaceutical Regulatory Authority (PRA). The main purpose of this body is to monitor the safety of medicines during the post marketing// surveillance process. Pharmaco, as the monitoring body is named would supervise all adverse reactions due to a part...
New Mexico Supreme Court Ruling Enhances Air Ambulance Safety
...lack & Davis law firm in Austin stated, "This decision affirms that hospitals are partners in the air ambulance safety process. Just as a hospital scrutinizes
physicians before selecting them to work in their facilities, they must also scrutinize air ambulance services. We have seen far too many crashes attr...
Trade-offs reveal no clear favorites in alternative energy market
Jeanne Guillemin warns that if history is any guide, states will again call on scientists to develop biological weapons;
Harold A. Feiveson scrutinizes
the environmental consequences of the Bush administrations Global Nuclear Energy Partnership;
Jennifer Ouellette explores how scientists can improve...
Poor diabetics: bitter times and worse times with no sweet respite
...mmunities world wide.
A report published recently by Diabetes UK and the all-party parliamentary group for diabetes (APPGD is an eye-opener which scrutinizes
the plight of the people living in deprived areas suffering from diabetes today and closely disseminates the links between diabetes which develops la...
Indian American Surgeon Wins US "Genius" Award
...blems faced by the surgeon-in-training with insight and compassion. In articles published in professional journals and mainstream periodicals, Gawande scrutinizes
the culture, protocol, and technology of modern medical practice from the perspective of a dedicated and empathetic professional.
In all his pub...
Cancer Drug Banned In Canada
...ected to die of the disease and nearly 20,000 people in Canada were estimated to have colorectal cancer.
The Patented Medicine Prices Review Board scrutinizes
the others like Germany, France, Italy, Sweden, Switzerland, the United Kingdom and the United States and put Canada at the top for drug costs.
Informed Medical Communications Highlights Opportunity in Revised PhRMA Code
... method for supporting biopharmaceutical brands.
Steve Budd, CEO of IMC commented, "Because of this changing regulatory
environment, IMC continually scrutinizes
the compliance of its services,
imbuing in our clients a confidence that IMC medical communications
services like our Moderator Advantage Programs (MA...